A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.
Journal
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
ISSN: 2078-5135
Titre abrégé: S Afr Med J
Pays: South Africa
ID NLM: 0404520
Informations de publication
Date de publication:
31 Mar 2021
31 Mar 2021
Historique:
received:
31
03
2021
entrez:
4
5
2021
pubmed:
5
5
2021
medline:
1
12
2021
Statut:
epublish
Résumé
Identification of patients on antiretroviral therapy (ART) with virological failure (VF) and the response in the public health sector remain significant challenges. We previously reported improvement in routine viral load (VL) monitoring after ART commencement through a health system-strengthening, nurse-led 'VL champion' programme as part of a multidisciplinary team in three public sector clinics in Durban, South Africa. To report on the impact of the VL champion model adapted to identify, support and co-ordinate the management of individuals with VF on first-line ART in a setting with limited electronic-based record capacity. We evaluated the VL champion model using a controlled before-after study design. A paper-based tool, the 'high VL register', was piloted under the supervision of the VL champion to improve data management, monitoring of counselling support, and enacting of clinical decisions. We abstracted chart and electronic data (TIER.net) for eligible individuals with VF in the year before and after implementation of the programme, and compared outcomes for individuals during these periods. Our primary outcome was successful completion of the VF pathway, defined as a repeat VL <1 000 copies/mL or a change to second-line ART within 6 months of VF. In a secondary analysis, we assessed the completion of each step in the pathway. We identified 60 and 56 individuals in the pre-intervention and post-intervention periods, respectively, with VF who met the inclusion criteria. Sociodemographic and clinical characteristics were similar between the periods. Repeat VL testing was completed in 61.7% and 57.8% of individuals in these two groups, respectively. We found no difference in the proportion achieving our primary outcome in the pre- and post-intervention periods: 11/60 (18.3%; 95% confidence interval (CI) 9 - 28) and 15/56 (22.8%; 95% CI 15 - 38), respectively (p=0.28). In multivariable logistic regression models adjusted for potential confounding factors, individuals in the post-intervention period had a non-significant doubling of the odds of achieving the primary outcome (adjusted odds ratio 2.07; 95% CI 0.75 - 5.72). However, there was no difference in the rates of completion of each step along the first-line VF cascade of care. This enhanced intervention to improve VF in the public sector using a paper-based data management system failed to achieve significant improvements in first-line VF management over the standard of care. In addition to interventions that better address patient-centred factors that contribute to VF, we believe that there are substantial limitations to and staffing requirements involved in the ongoing utilisation of a paper-based tool. A prioritisation is needed to further expand and upgrade the electronic medical record system with capabilities for prompting staff regarding patients with missed visits and critical laboratory results demonstrating VF.
Sections du résumé
BACKGROUND
BACKGROUND
Identification of patients on antiretroviral therapy (ART) with virological failure (VF) and the response in the public health sector remain significant challenges. We previously reported improvement in routine viral load (VL) monitoring after ART commencement through a health system-strengthening, nurse-led 'VL champion' programme as part of a multidisciplinary team in three public sector clinics in Durban, South Africa.
OBJECTIVES
OBJECTIVE
To report on the impact of the VL champion model adapted to identify, support and co-ordinate the management of individuals with VF on first-line ART in a setting with limited electronic-based record capacity.
METHODS
METHODS
We evaluated the VL champion model using a controlled before-after study design. A paper-based tool, the 'high VL register', was piloted under the supervision of the VL champion to improve data management, monitoring of counselling support, and enacting of clinical decisions. We abstracted chart and electronic data (TIER.net) for eligible individuals with VF in the year before and after implementation of the programme, and compared outcomes for individuals during these periods. Our primary outcome was successful completion of the VF pathway, defined as a repeat VL <1 000 copies/mL or a change to second-line ART within 6 months of VF. In a secondary analysis, we assessed the completion of each step in the pathway.
RESULTS
RESULTS
We identified 60 and 56 individuals in the pre-intervention and post-intervention periods, respectively, with VF who met the inclusion criteria. Sociodemographic and clinical characteristics were similar between the periods. Repeat VL testing was completed in 61.7% and 57.8% of individuals in these two groups, respectively. We found no difference in the proportion achieving our primary outcome in the pre- and post-intervention periods: 11/60 (18.3%; 95% confidence interval (CI) 9 - 28) and 15/56 (22.8%; 95% CI 15 - 38), respectively (p=0.28). In multivariable logistic regression models adjusted for potential confounding factors, individuals in the post-intervention period had a non-significant doubling of the odds of achieving the primary outcome (adjusted odds ratio 2.07; 95% CI 0.75 - 5.72). However, there was no difference in the rates of completion of each step along the first-line VF cascade of care.
CONCLUSIONS
CONCLUSIONS
This enhanced intervention to improve VF in the public sector using a paper-based data management system failed to achieve significant improvements in first-line VF management over the standard of care. In addition to interventions that better address patient-centred factors that contribute to VF, we believe that there are substantial limitations to and staffing requirements involved in the ongoing utilisation of a paper-based tool. A prioritisation is needed to further expand and upgrade the electronic medical record system with capabilities for prompting staff regarding patients with missed visits and critical laboratory results demonstrating VF.
Identifiants
pubmed: 33944759
doi: 10.7196/SAMJ.2021.v111i4.15432
pmc: PMC8100970
mid: NIHMS1664476
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
299-303Subventions
Organisme : NIAID NIH HHS
ID : R01 AI124718
Pays : United States
Références
AIDS. 2019 Aug 1;33(10):1635-1644
pubmed: 31305331
Public Health Action. 2018 Dec 21;8(4):225-231
pubmed: 30775284
Int Health. 2017 Jul 1;9(4):206-214
pubmed: 28810670
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
PLoS One. 2019 Sep 10;14(9):e0222229
pubmed: 31504060
Clin Infect Dis. 2008 May 15;46(10):1589-97
pubmed: 18419495
BMC Infect Dis. 2017 Aug 22;17(1):582
pubmed: 28830382
Trop Med Int Health. 2016 Sep;21(9):1115-23
pubmed: 27300077
HIV Med. 2020 Aug;21(7):457-462
pubmed: 32495515
J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):370-80
pubmed: 22820803
Bull World Health Organ. 2008 Dec;86(12):939-47
pubmed: 19142294
Lancet HIV. 2015 Jul;2(7):e271-8
pubmed: 26423252
EClinicalMedicine. 2020 Jan 05;18:100231
pubmed: 31922120
AIDS Res Hum Retroviruses. 2017 Dec;33(12):1181-1184
pubmed: 28793781
Curr HIV/AIDS Rep. 2016 Dec;13(6):359-366
pubmed: 27739018
PLoS Med. 2019 Jul 23;16(7):e1002874
pubmed: 31335865
Nature. 2015 Dec 3;528(7580):S68-76
pubmed: 26633768
HIV Clin Trials. 2017 Jul;18(4):149-155
pubmed: 28720039
Trop Med Int Health. 2018 Dec;23(12):1314-1325
pubmed: 30281882
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
Afr J Prim Health Care Fam Med. 2015 Jul 30;7(1):
pubmed: 26245622
South Afr J HIV Med. 2017 Jul 15;18(1):776
pubmed: 29568644
Lancet Infect Dis. 2016 May;16(5):565-575
pubmed: 26831472